The F.D.A.’s Extraordinary Approval of a Questionable Treatment for Alzheimer’s  The New YorkerUS approves first new Alzheimer’s drug in 20 years  BBC NewsBiogen Alzheimer’s drug and the battle over dementia treatment of the future  CNBCHow the new Alzheimer’s drug works—and why the FDA is under fire for approving it  National GeographicA new Alzheimer’s drug has been approved. But should […]

New Treatment Stops Progression of Alzheimer’s Disease in Monkey Brains  NYU Langone Health Go to News Source

Florida home to more than 9 percent of U.S. Alzheimer’s patients, data shows  WFLA Go to News Source

Alzheimers Q&A: How do I maintain my sense of well-being after an Alzheimer’s diagnosis?  The Advocate Go to News Source

How the new Alzheimer’s drug works—and why the FDA is under fire for approving it  National GeographicBiogen Alzheimer’s drug and the battle over dementia treatment of the future  CNBCNew Alzheimer’s drug sparks backlash over FDA, pricing | TheHill  The Hill3 Experts Quit An FDA Panel Over Alzheimer’s Drug Approval  NPRThe Alzheimer’s economy: is the new $56,000-a-year drug worth it?  Financial […]

COVID-19 Linked With Alzheimer’s Disease-Like Dementia  Contagionlive.com Go to News Source

Biogen Alzheimer’s drug and the battle over dementia treatment of the future  CNBCHow the new Alzheimer’s drug works—and why the FDA is under fire for approving it  National Geographic3 Experts Quit An FDA Panel Over Alzheimer’s Drug Approval  NPRAlzheimer’s Association Statement: Next Steps For New Alzheimer’s Treatment  PRNewswireThe Alzheimer’s economy: is the new $56,000-a-year drug worth it?  Financial TimesView Full […]

Alumnus studies genetic factors for Alzheimer’s disease  FIU News Go to News Source

Three F.D.A. Advisers Resign Over Approval of Alzheimer’s Drug  The New York TimesControversial New Alzheimer’s Drug: What to Know  WebMDNew Alzheimer’s drug won’t ‘bring Mom back to two years ago,’ doctor says  NBC NewsNew Alzheimer’s drug aducanumab: cost, side effects, timeline and other questions answered  CNN FDA’s Approval of Alzheimer’s Drug Leads to Third Adviser’s Resignation  The Wall Street JournalView […]

3 Experts Quit An FDA Panel Over Alzheimer’s Drug Approval  NPR Go to News Source